"Somos, en total, más de 3.000 profesionales y nuestra razón de ser es el bienestar y la salud de la población que cuidamos."

During the past decade, Complejo Hospitalario Torrecardenas; Servicio de Oncologia conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Complejo Hospitalario Torrecardenas; Servicio de Oncologia" are "Breast Cancer" (1 trials), "Hepatocellular Carcinoma" (1 trials), "Non-Small Cell Lung Cancer" (1 trials), "Small Cell Lung Cancer" (1 trials) and "Urothelial Carcinoma" (1 trials). Many other conditions were trialed in "Complejo Hospitalario Torrecardenas; Servicio de Oncologia" in a lesser frequency.

Most popular intervention types in "Complejo Hospitalario Torrecardenas; Servicio de Oncologia" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Capecitabine" (1 trials), "Pertuzumab" (1 trials) and "Trastuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Complejo Hospitalario Torrecardenas; Servicio de Oncologia" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Complejo Hospitalario Torrecardenas; Servicio de Oncologia". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Complejo Hospitalario Torrecardenas; Servicio de Oncologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Complejo Hospitalario Torrecardenas; Servicio de Oncologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".